Prevalence and risk factors for reduced pulmonary function in diabetic patients: The Korea National Health and Nutrition Examination Survey
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: An association between reduced pulmonary function and diabetes has been observed. Our aim was to evaluate the prevalence and risk factors associated with reduced pulmonary function in diabetic patients. Methods: We analyzed data from the Korea National Health and Nutrition Examination Survey 2011 to 2013. The study population included data from 8,784 participants (including 1,431 diabetics) aged ≥ 40 years. Reduced pulmonary function was defined as patients with restrictive (forced expiratory volume in 1 second/ forced vital capacity [FEV1/FVC] ≥ 0.7 and FVC < 80% of predicted value) or obstructive (FEV1/FVC < 0.7) patterns. Results: Subjects with diabetes had a higher prevalence of restrictive (18.4% vs. 9.4%, p < 0.001) and obstructive impairments (20% vs. 12.6%, p < 0.001) than those without diabetes. The adjusted odds ratios (aORs) (95% confidence interval [CI]) for obstructive and restrictive pulmonary impairment were 0.91 (0.75 to 1.11) and 1.57 (1.30 to 1.89), respectively. In the diabetes population, age (aOR, 1.04; 95% CI, 1.02 to 1.06), male sex (aOR, 1.40; 95% CI, 1.04 to 1.88), and body mass index (aOR, 1.15; 95% CI, 1.10 to 1.21) were independently associated with restrictive pulmonary impairment. Age (aOR, 1.12; 95% CI, 1.09 to 1.14), male sex (aOR, 4.24; 95% CI, 2.42 to 7.44), and smoking at any point (ever-smoker: aOR, 1.96; 95% CI, 1.16 to 3.33) were independent risk factors for obstructive pulmonary impairment in diabetics. Diabetes duration or glycated hemoglobin had no association with pulmonary impairment in diabetes. Conclusions: Subjects with diabetes had a higher risk of restrictive pulmonary impairment than those without diabetes after adjusting for confounding factors. Older age, male sex, body mass index, and smoking were associated with reduced lung function in diabetes.
Abstract
Background/Aims: An association between reduced pulmonary function and diabetes has been observed. Our aim was to evaluate the prevalence and risk factors associated with reduced pulmonary function in diabetic patients. Methods: We analyzed data from the Korea National Health and Nutrition Examination Survey 2011 to 2013. The study population included data from 8,784 participants (including 1,431 diabetics) aged ≥ 40 years. Reduced pulmonary function was defined as patients with restrictive (forced expiratory volume in 1 second/ forced vital capacity [FEV1/FVC] ≥ 0.7 and FVC < 80% of predicted value) or obstructive (FEV1/FVC < 0.7) patterns. Results: Subjects with diabetes had a higher prevalence of restrictive (18.4% vs. 9.4%, p < 0.001) and obstructive impairments (20% vs. 12.6%, p < 0.001) than those without diabetes. The adjusted odds ratios (aORs) (95% confidence interval [CI]) for obstructive and restrictive pulmonary impairment were 0.91 (0.75 to 1.11) and 1.57 (1.30 to 1.89), respectively. In the diabetes population, age (aOR, 1.04; 95% CI, 1.02 to 1.06), male sex (aOR, 1.40; 95% CI, 1.04 to 1.88), and body mass index (aOR, 1.15; 95% CI, 1.10 to 1.21) were independently associated with restrictive pulmonary impairment. Age (aOR, 1.12; 95% CI, 1.09 to 1.14), male sex (aOR, 4.24; 95% CI, 2.42 to 7.44), and smoking at any point (ever-smoker: aOR, 1.96; 95% CI, 1.16 to 3.33) were independent risk factors for obstructive pulmonary impairment in diabetics. Diabetes duration or glycated hemoglobin had no association with pulmonary impairment in diabetes. Conclusions: Subjects with diabetes had a higher risk of restrictive pulmonary impairment than those without diabetes after adjusting for confounding factors. Older age, male sex, body mass index, and smoking were associated with reduced lung function in diabetes.
참고문헌 (26)
- 전자영, "Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c", Diabetes and Metabolism Journal, 37(5), pp.349~357 (2013), 대한당뇨병학회[DOI]
- 전자영, "Current Status of Glycemic Control of Patients with Diabetes in Korea: The Fifth Korea National Health and Nutrition Examination Survey", Diabetes and Metabolism Journal, 38(3), pp.197~203 (2014), 대한당뇨병학회[DOI]
- Davis TM, "Reduced pulmonary function and its associations in type 2diabetes: the Fremantle Diabetes Study", Diabetes Res Clin Pract, 50, pp.153~159 (2000)
- Yeh HC, "Cross-sectional and prospective study of lung function in adults with type 2diabetes: the Atherosclerosis Risk in Communities (ARIC)study", Diabetes Care, 31, pp.741~746 (2008)
- Lange P, "Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults", Eur Respir J, 20, pp.1406~1412 (2002)
- Litonjua AA, "Lung function in type 2 diabetes: the Normative Aging Study", Respir Med, 99, pp.1583~1590 (2005)
- Klein OL, "Systematic review of the association between lung function and type 2diabetes mellitus", Diabet Med, 27, pp.977~987 (2010)
- van den Borst B, "Pulmonary function in diabetes: a metaanalysis", Chest, 138, pp.393~406 (2010)
- Kim DS, "Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey", Am J Respir Crit Care Med, 172, pp.842~847 (2005)
- 황용일, "Prevalence of Chronic Obstructive Pulmonary Disease in Korea: The Result of Forth Korean National Health and Nutrition Examination Survey", Tuberculosis and Respiratory Diseases, 71(5), pp.328~334 (2011), 대한결핵및호흡기학회
- 이정연, "Prevalence of Spirometrically-defined Restrictive Ventilatory Defect in Korea: The Fourth-2, 3, and Fifth Korean National Health and Nutrition Examination Survey, 2008-2012", Journal of Korean Medical Science, 30(6), pp.725~732 (2015), 대한의학회
- American Thoracic Society., "Standardization of spirometry, 1994 update", Am J Respir Crit Care Med, 152, pp.1107~1136 (1995)
- 최정근, "한국인의 정상 폐활량 예측치", Tuberculosis and Respiratory Diseases, 58(3), pp.230~242 (2005), 대한결핵및호흡기학회
- Evans SE, "Current practice in pulmonary function testing", Mayo Clin Proc, 78, pp.758~763 (2003)
- Mannino DM, "Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination", Am J Med, 114, pp.758~762 (2003)
- Mannino DM, "Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study", Respir Med, 100, pp.115~122 (2006)
- Mannino DM, "Preva-lence and outcomes of diabetes, hypertension and cardiovascular disease in COPD", Eur Respir J, 32, pp.962~969 (2008)
- Kim HK, "Association of restrictive ventilatory dysfunction with insulin resistance and type 2 diabetes in Koreans", Exp Clin Endocrinol Diabetes, 119, pp.47~52 (2011)
- Oda E, "A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population", Environ Health Prev Med, 14, pp.284~291 (2009)
- Walter RE, "Association between glycemic state and lung function:the Framingham Heart Study", Am J Respir Crit Care Med, 167, pp.911~916 (2003)
- Sharma G, "Effect of aging on respiratory system physiology and immunology", Clin Interv Aging, 1, pp.253~260 (2006)
- Enzi G, "Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography", Am J Clin Nutr, 44, pp.739~746 (1986)
- Canoy D, "Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom", Am J Epidemiol, 159, pp.1140~1149 (2004)
- Melo LC, "Obesity and lung function:a systematic review", Einstein (Sao Paulo), 12, pp.120~125 (2014)
- Bano R, "Study of lung functions in smokers and non-smokers in rural India", Indian J Physiol Pharmacol, 55, pp.84~88 (2011)
- Boskabady MH, "Pulmonary function tests and respiratory symptoms among smokers in the city of Mashhad (north east of Iran)", Rev Port Pneumol, 17, pp.199~204 (2011)